Article
Licensed
Unlicensed
Requires Authentication
Vancomycin assay interference: low-level IgM paraprotein disrupts Siemens Atellica® CH VANC assay
-
Stijn De koninck
, Sofie Dhaese
Published/Copyright:
April 16, 2025
Received: 2025-03-03
Accepted: 2025-04-04
Published Online: 2025-04-16
Published in Print: 2025-07-28
© 2025 Walter de Gruyter GmbH, Berlin/Boston
You are currently not able to access this content.
You are currently not able to access this content.
Articles in the same Issue
- Frontmatter
- Editorial
- Setting analytical performance specification by simulation (Milan model 1b)
- Reviews
- Unveiling the power of R: a comprehensive perspective for laboratory medicine data analysis
- Clostebol detection after transdermal and transmucosal contact. A systematic review
- Opinion Papers
- A value-based score for clinical laboratories: promoting the work of the new EFLM committee
- Digital metrology in laboratory medicine: a call for bringing order to chaos to facilitate precision diagnostics
- Perspectives
- Supporting prioritization efforts of higher-order reference providers using evidence from the Joint Committee for Traceability in Laboratory Medicine database
- Clinical vs. statistical significance: considerations for clinical laboratories
- Genetics and Molecular Diagnostics
- Reliable detection of sex chromosome abnormalities by quantitative fluorescence polymerase chain reaction
- Targeted proteomics of serum IGF-I, -II, IGFBP-2, -3, -4, -5, -6 and ALS
- Candidate Reference Measurement Procedures and Materials
- Liquid chromatography tandem mass spectrometry (LC-MS/MS) candidate reference measurement procedure for urine albumin
- General Clinical Chemistry and Laboratory Medicine
- Patient risk management in laboratory medicine: an international survey to assess the severity of harm associated with erroneous reported results
- Exploring the extent of post-analytical errors, with a focus on transcription errors – an intervention within the VIPVIZA study
- A survey on measurement and reporting of total testosterone, sex hormone-binding globulin and free testosterone in clinical laboratories in Europe
- Quality indicators in laboratory medicine: a 2020–2023 experience in a Chinese province
- Impact of delayed centrifugation on the stability of 32 biochemical analytes in blood samples collected in serum gel tubes and stored at room temperature
- Concordance between the updated Elecsys cerebrospinal fluid immunoassays and amyloid positron emission tomography for Alzheimer’s disease assessment: findings from the Apollo study
- Novel protocol for metabolomics data normalization and biomarker discovery in human tears
- Use of the BIOGROUP® French laboratories database to conduct CKD observational studies: a pilot EPI-CKD1 study
- Reference Values and Biological Variations
- Consensus instability equations for routine coagulation tests
- Hematology and Coagulation
- Flow-cytometric lymphocyte subsets enumeration: comparison of single/dual-platform method in clinical laboratory with dual-platform extended PanLeucogating method in reference laboratory
- Cardiovascular Diseases
- Novel Mindray high sensitivity cardiac troponin I assay for single sample and 0/2-hour rule out of myocardial infarction: MERITnI study
- Infectious Diseases
- Cell population data for early detection of sepsis in patients with suspected infection in the emergency department
- Letters to the Editor
- Lab Error Finder: A call for collaboration
- Cascading referencing of terms and definitions
- Strengthening international cooperation and confidence in the field of laboratory medicine by ISO standardization
- Determining the minimum blood volume required for laboratory testing in newborns
- Performance evaluation of large language models with chain-of-thought reasoning ability in clinical laboratory case interpretation
- Vancomycin assay interference: low-level IgM paraprotein disrupts Siemens Atellica® CH VANC assay
- Dr. Morley Donald Hollenberg. An extraordinary scientist, teacher and mentor
Keywords for this article
vancomycin;
therapeutic drug monitoring (TDM);
interference;
paraprotein;
immunoassay
Articles in the same Issue
- Frontmatter
- Editorial
- Setting analytical performance specification by simulation (Milan model 1b)
- Reviews
- Unveiling the power of R: a comprehensive perspective for laboratory medicine data analysis
- Clostebol detection after transdermal and transmucosal contact. A systematic review
- Opinion Papers
- A value-based score for clinical laboratories: promoting the work of the new EFLM committee
- Digital metrology in laboratory medicine: a call for bringing order to chaos to facilitate precision diagnostics
- Perspectives
- Supporting prioritization efforts of higher-order reference providers using evidence from the Joint Committee for Traceability in Laboratory Medicine database
- Clinical vs. statistical significance: considerations for clinical laboratories
- Genetics and Molecular Diagnostics
- Reliable detection of sex chromosome abnormalities by quantitative fluorescence polymerase chain reaction
- Targeted proteomics of serum IGF-I, -II, IGFBP-2, -3, -4, -5, -6 and ALS
- Candidate Reference Measurement Procedures and Materials
- Liquid chromatography tandem mass spectrometry (LC-MS/MS) candidate reference measurement procedure for urine albumin
- General Clinical Chemistry and Laboratory Medicine
- Patient risk management in laboratory medicine: an international survey to assess the severity of harm associated with erroneous reported results
- Exploring the extent of post-analytical errors, with a focus on transcription errors – an intervention within the VIPVIZA study
- A survey on measurement and reporting of total testosterone, sex hormone-binding globulin and free testosterone in clinical laboratories in Europe
- Quality indicators in laboratory medicine: a 2020–2023 experience in a Chinese province
- Impact of delayed centrifugation on the stability of 32 biochemical analytes in blood samples collected in serum gel tubes and stored at room temperature
- Concordance between the updated Elecsys cerebrospinal fluid immunoassays and amyloid positron emission tomography for Alzheimer’s disease assessment: findings from the Apollo study
- Novel protocol for metabolomics data normalization and biomarker discovery in human tears
- Use of the BIOGROUP® French laboratories database to conduct CKD observational studies: a pilot EPI-CKD1 study
- Reference Values and Biological Variations
- Consensus instability equations for routine coagulation tests
- Hematology and Coagulation
- Flow-cytometric lymphocyte subsets enumeration: comparison of single/dual-platform method in clinical laboratory with dual-platform extended PanLeucogating method in reference laboratory
- Cardiovascular Diseases
- Novel Mindray high sensitivity cardiac troponin I assay for single sample and 0/2-hour rule out of myocardial infarction: MERITnI study
- Infectious Diseases
- Cell population data for early detection of sepsis in patients with suspected infection in the emergency department
- Letters to the Editor
- Lab Error Finder: A call for collaboration
- Cascading referencing of terms and definitions
- Strengthening international cooperation and confidence in the field of laboratory medicine by ISO standardization
- Determining the minimum blood volume required for laboratory testing in newborns
- Performance evaluation of large language models with chain-of-thought reasoning ability in clinical laboratory case interpretation
- Vancomycin assay interference: low-level IgM paraprotein disrupts Siemens Atellica® CH VANC assay
- Dr. Morley Donald Hollenberg. An extraordinary scientist, teacher and mentor